Inventor · disambiguated record
Marianne Dragheim
Also filed as: DRAGHEIM MARIANNE
3 granted patents·7 pending applications·9 citations·filing 2008–2023
66Inventor score
Top patents by PatentIndex Score
10 records- 0181US11628166B2Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activityH LUNDBECK AS·Filed 2020·Granted Apr 18, 2023·1 cites·9 claims
- 0278US2024082239A1Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a ActivityH LUNDBECK AS·Filed 2023·Application pending·0 cites
- 0377US9744166B2Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activityH LUNDBECK AS·Filed 2016·Granted Aug 29, 2017·2 cites·9 claims
- 0476US9278096B2Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activityDRAGHEIM MARIANNE·Filed 2008·Granted Mar 8, 2016·6 cites·26 claims
- 0576US2024293397A1Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2023·Application pending·0 cites
- 0670US2022370439A1Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 0763US2021085674A1Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 0857US2019000836A1Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazineH LUNDBECK AS·Filed 2018·Application pending·0 cites
- 0956US2018161321A1Therapeutic Uses of Compounds Having Combined SERT, 5-HT3 and 5-HT1A ActivityH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1046US2013184291A1Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsuflanyl)phenyl]piperazineDRAGHEIM MARIANNE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marianne Dragheim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →